Our mission is to conduct quality research that advances modern and innovative treatment options. The health and safety of our patients is our primary focus. Working together with the pharmaceutical industry, Lincoln Research is able to bring innovative treatment opportunities to Rhode Island, Massachusetts and Connecticut.
We specialize in the medical study of depression, bipolar depression, schizophrenia, smoking cessation, attention deficit and anxiety.
In addition to Dr. James Whalen, a Board-Certified Psychiatrist, the research staff consists of Certified Clinical Research Coordinators and qualified Research Assistants. Our research group strives to deliver the highest quality care to our patients and ensure they are treated with respect.
Care is provided in a confidential manner and our staff is available to address patients' questions and concerns throughout their participation in the study.